Indefinite Delivery Contract N6264523D5013

Award Date 8/1/23
Last Date to Order 7/31/26
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of the Navy Bureau of Medicine and Surgery awarded a single award indefinite delivery contract to Alere San Diego, Inc. DBA Immunalysis Corp. with a potential value of $2,355,383.84 to procure FENTANYL/NORFENTANYL IMMUNOASSAY REAGENT. No set aside provision was used for this contract. The contract includes four firm fixed price delivery orders awarded to Alere San Diego, Inc. DBA Immunalysis Corp. for quantities of FENTANYL/NORFENTANYL IMMUNOASSAY REAGENT ranging from $84,833.74...
The Department of the Navy Bureau of Medicine and Surgery awarded a single award Indefinite Delivery Contract to Alere San Diego, Inc. DBA Immunalysis Corp. for the delivery of fentanyl and norfentanyl immunoassay reagent kits. The contract has a potential value of $2.67M and a period of performance through October 2023. Under the contract, Immunalysis Corp. was issued several firm fixed price delivery orders by Navy and Defense Health Agency customers totaling over $1.3M to supply...
The Naval Medical Logistics Command awarded a single-award IDV contract to Alere San Diego, Inc. DBA Immunalysis Corp. to provide fentanyl drug testing reagents for the Drug Demand Reduction Program. Task orders issued against the IDV by various military medical commands procured immunoassay reagents and kits from Immunalysis Corp. to support substance abuse screening programs. Reagents were acquired for fentanyl, norfentanyl, and differentiating fentanyl from non-fentanyl substances. Delivery...
The Naval Medical Logistics Command awarded an indefinite-delivery contract to Siemens Healthcare Diagnostics Inc. to supply cannabinoid immunoassay reagent kits in support of the Department of Defense Drug Demand Reduction Program. The contract has a five-year ordering period from June 2021 through June 2026 with an estimated value of $750,270. Task orders issued against the contract by various military medical agencies require Siemens to provide the immunoassay kits used to detect cannabinoids...
The Department of the Navy Bureau of Medicine and Surgery awarded Siemens Healthcare Diagnostics Inc. an indefinite delivery contract with a potential value of $249,985.26 for the delivery of LSD reagent kits. Under this contract, Siemens Healthcare Diagnostics Inc. received ten delivery orders from various Department of Defense agencies totaling $249,985.26 to supply LSD reagent kits for use in forensic toxicology drug testing laboratories. The reagent kits will support substance identification...
The Department of the Navy Bureau of Medicine and Surgery (BUMED) awarded an Indefinite Delivery Contract (IDC) valued at $825,606.25 to Siemens Healthcare Diagnostics Inc., a subsidiary of Siemens Aktiengesellschaft, to provide amphetamine (AMP) and methamphetamine (METH) reagent kits and associated laboratory diagnostic equipment and services. The contract was awarded on June 17, 2019 without any set-aside designations. Under the IDC, Siemens Healthcare Diagnostics has received multiple firm...
The federal contract IDV award N0018924DZ016 is a $4,125,000 single-award Indefinite Delivery Contract issued by the Naval Supply Systems Command, a defense agency, to Siemens Healthcare Diagnostics Inc. The contract has a period of performance through September 30, 2029 and is for the procurement of LSD reagent kits and related products to support the Defense Department's Directed Drug Reduction Program (DDRP). Siemens Healthcare Diagnostics Inc., a subsidiary of Siemens Aktiengesellschaft,...
Siemens Healthcare Diagnostics Inc., a subsidiary of Siemens Aktiengesellschaft, has been awarded multiple firm fixed price delivery orders by various U.S. federal agencies to provide 6-AM reagent kits and related laboratory diagnostic products and services. The Department of the Navy Bureau of Medicine and Surgery, Department of the Air Force Air Education and Training Command, Defense Health Agency, and Department of the Army Medical Command have all issued awards to Siemens Healthcare...
The Department of Defense awarded a series of single-award indefinite delivery contracts and delivery orders to Alere San Diego, Inc. (doing business as Immunalysis), a manufacturer of immunoassay reagents and test kits for drugs of abuse screening and other small molecule detection. The contracts, valued at over $15 million in potential orders, support substance testing programs across various federal agencies including the Departments of Defense, Transportation, Justice, and Veterans...
The Department of the Navy Bureau of Medicine and Surgery awarded a single award indefinite delivery/indefinite quantity contract to Franklin Young International, Incorporated with a potential value of $1,321,320. Task orders issued against the contract procure BZE reagent kits to support medical testing programs conducted by multiple military medical commands and agencies. Notable requirements include orders awarded by the Navy Bureau of Medicine and Surgery ranging from $4,290 to $25,740...
  • N6264523D5013
    Indefinite Delivery Contract
  • 19
    Federal Contract Awards

The Department of the Navy Bureau of Medicine and Surgery awarded Siemens Healthcare Diagnostics Inc. a single award indefinite delivery contract with a potential value of $4,504,500 to provide fentanyl reagent kits. Under this contract vehicle, Siemens Healthcare Diagnostics Division has received four firm fixed price delivery orders totaling $546,000 to supply ARK FENTANYL II products and services in support of the Bureau's medical research and healthcare programs. Performance is to take place at the contractor's Sleepy Hollow, New York facility through periods ranging from one week to three months concluding in October 2023.

The originating pre-solicitation notice indicated that Naval Medical Readiness Logistics Command intends to procure FDA-approved fentanyl immunoassay drug testing kits capable of detecting the drug in urine samples down to a 1ng/mL concentration. The reagent must be compatible for use on Beckman Coulter AU5800 Series Clinical Chemistry analyzers. The resulting contract is expected to have a single awardee, indefinite delivery structure with a minimum guarantee of 100 kits and maximum monthly demand of 500,000 tests across six toxicology laboratories. The ordering period will run from November 2023 through October 2026.

Generated 1/5/24, 12:14 AM